Cambridge Innovation Capital

In a Phase 1/2 study of 38 patients, one had a complete disappearance of cancer signs and 16 had tumors shrink by at least 30%. The analyzed patients received a dose of BT8009 that Bicycle is advancing toward registrational development.

Or listen to the podcast Podcast run time: 9 minutes 50 seconds

The article profiles Dr Giorgia Longobardi, co-founder and CEO of Cambridge GaN Devices, and discusses her experience spinning out a startup, women in STEM, energy-efficient microchips and the UK’s semiconductor strategy.

The page describes real-time UIs as a technology shift that changes business users’ expectations and discusses Nstream’s real-time UIs.

Cambridge GaN Devices CTO Professor Florin Udrea presented the ICeGaN Combo concept at the International Electron Devices Meeting on December 11. The concept integrates an intelligent GaN HEMT (ICeGaN) and an IGBT in parallel.

CIC in the news and events information

Ways to contact Cambridge Innovation Capital

Cambridge Innovation Capital identifies and supports entrepreneurs in knowledge-intensive businesses, drawing on its expertise and position in a science and technology ecosystem.

The privacy policy explains how Cambridge Innovation Capital Limited and its subsidiaries, including Cambridge Innovation Capital Manager Limited, process personal information and describes individuals’ rights.

Terms of use

Salience Labs raises $125 million in Series B funding to scale its all-optical switching technology for AI data centers. Led by Bullhound Capital, the round includes Intel Capital, AMD Ventures, SBI Group, Hudson River Trading and British Business Bank, alongside returning investors. The company has demonstrated a 64-port all-optical photonic switch and plans to use the funding for manufacturing, geographic expansion and research on higher-density switches.

Oct 2026 · SiliconANGLENews article